팝업레이어 알림

MEDIFIC Bio

is drugging the undruggable targets with high unmet needs to treat hard-to-treat diseases.

Background image

MEDIFIC Bio

is drugging the undruggable target in the preclinical stage to treat GBM, NSCLC, HCC, and MASH.

Background image

MEDIFIC
Bio

is drugging the follow-up undruggable targets
by developing the platform technology through open & collaborative innovation.

Thank you!

Background image

VALUES

Translating and Innovating Deep Science into Drug Discovery and Development
for the Treatment of Cancer and Better Life of the Patients.

  • Understanding of
    Deep Science

  • Open Innovation and
    Optimized R&D System

  • Patient and Market-oriented
    Value Creation

  • Better Teamwork and
    Sustainable Growth

MEDIFIC's Keywords

  • Cancer
    Stem Cell
  • First-in-class
  • Targeted
    Protein
    Degradation
  • Exosome
  • Platform
    Technology
  • Targeted
    Therapy

MEDIFIC

Development of first-in-class anticancer drugs for targeting cancer stem cell
Development of exosome-based cancer immunotherapy

CANCER STEM CELL

CSCs have been recognized as a key target
for successful cancer treatment.

VIEW MORE

EXOSOME

Exosomes are valuable therapeutic modality
because of their multiple advantages.

VIEW MORE

PIPELINE

MEDIFIC has core competencies
to meet a variety of unmet medical needs.

VIEW MORE